BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21057810)

  • 21. EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust.
    Berg J; Fjellbirkeland L; Suhrke P; Jebsen P; Lund-Iversen M; Kleinberg L; Helgeland L; Brustugun OT; Helland Å
    Acta Oncol; 2016; 55(2):149-55. PubMed ID: 26313507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
    Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
    Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.
    Kato Y; Peled N; Wynes MW; Yoshida K; Pardo M; Mascaux C; Ohira T; Tsuboi M; Matsubayashi J; Nagao T; Ikeda N; Hirsch FR
    J Thorac Oncol; 2010 Oct; 5(10):1551-8. PubMed ID: 20697298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies.
    Ho HL; Kao HL; Yeh YC; Chou TY
    Diagn Pathol; 2019 Jun; 14(1):59. PubMed ID: 31221183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of EGFR somatic mutations in non-small cell lung cancer (NSCLC) using a novel mutant-enriched liquidchip (MEL) technology.
    Zhang L; Yang H; Zhao Y; Liu W; Wu S; He J; Luo X; Zhu Z; Xu J; Zhou Q; Ren-Heidenreich L
    Curr Drug Metab; 2012 Sep; 13(7):1007-11. PubMed ID: 22591345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chinese Expert Consensus on Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations (2023 Edition)].
    Chinese Society of Clinical Oncology (CSCO) Non-small Cell Lung Cancer Committee
    Zhongguo Fei Ai Za Zhi; 2023 May; 26(5):325-337. PubMed ID: 37316442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non-Small-cell Lung Cancer.
    Kim E; Feldman R; Wistuba II
    Clin Lung Cancer; 2018 Mar; 19(2):105-114. PubMed ID: 28935493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients.
    Wu W; Cao Z; Zhang W; Zhang L; Hou L; Wu C
    Diagn Pathol; 2020 Jan; 15(1):9. PubMed ID: 32005253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.
    Leary AF; Castro DG; Nicholson AG; Ashley S; Wotherspoon A; O'Brien ME; Popat S
    Eur J Cancer; 2012 Jan; 48(1):61-7. PubMed ID: 22036089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.
    Kawahara A; Azuma K; Sumi A; Taira T; Nakashima K; Aikawa E; Abe H; Yamaguchi T; Takamori S; Akiba J; Kage M
    Lung Cancer; 2011 Oct; 74(1):35-40. PubMed ID: 21444121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of
    Bai H; Xia J; Zhao X; Gong Z; Zhang D; Xiong L
    J Clin Pathol; 2019 May; 72(5):379-385. PubMed ID: 30787028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis.
    Li WY; Zhao TT; Xu HM; Wang ZN; Xu YY; Han Y; Song YX; Wu JH; Xu H; Yin SC; Liu XY; Miao ZF
    BMC Cancer; 2019 Feb; 19(1):145. PubMed ID: 30760227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
    Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
    Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in epidermal growth factor receptor gene mutations and relationship with clinicopathological features in NSCLC between Uygur and Han ethnic groups.
    Zhang Y; Wang Q; Han ZG; Shan L
    Asian Pac J Cancer Prev; 2013; 14(5):2879-83. PubMed ID: 23803047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of EGFR mutations in non-small cell lung cancer patients: screening data from West Siberia.
    Gervas P; Ivanova A; Vasiliev N; Ananina O; Zharkova O; Rogovieva O; Verzhbitskaya N; Didichuk I; Cheremisina O; Popova N; Goldberg V; Cherdyntsev E; Choynzonov E; Cherdyntseva N
    Asian Pac J Cancer Prev; 2015; 16(2):689-92. PubMed ID: 25684509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytological-negative pleural effusion can be an alternative liquid biopsy media for detection of EGFR mutation in NSCLC patients.
    Song Z; Wang W; Li M; Liu J; Zhang Y
    Lung Cancer; 2019 Oct; 136():23-29. PubMed ID: 31421258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC.
    Baraibar I; Mezquita L; Gil-Bazo I; Planchard D
    Crit Rev Oncol Hematol; 2020 Apr; 148():102906. PubMed ID: 32109716
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Sukari A; Nagasaka M; Wakeling E
    J Natl Compr Canc Netw; 2017 Oct; 15(10):1188-1192. PubMed ID: 28982744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [EGFR mutation analysis in non-small-cell lung cancer : Experience from routine diagnostics].
    Tapia C; Savic S; Bihl M; Rufle A; Zlobec I; Terracciano L; Bubendorf L
    Pathologe; 2009 Sep; 30(5):384-92. PubMed ID: 19357847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour content ratio matters for detecting epidermal growth factor receptor mutation by cobas test in small biopsies; a retrospective study.
    Kogo M; Fujimoto D; Hosoya K; Nagata K; Nakagawa A; Tachikawa R; Yamashita D; Kitamura Y; Imai Y; Tomii K
    BMC Cancer; 2020 Feb; 20(1):104. PubMed ID: 32028905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.